Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Maya Nourieh"'
Autor:
Virginie Firlej, Pascale Soyeux, Maya Nourieh, Eric Huet, Fannie Semprez, Yves Allory, Arturo Londono-Vallejo, Alexandre de la Taille, Francis Vacherot, Damien Destouches
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 9, p 4491 (2022)
Prostate cancer (PCa) is the second most frequent cancer and the fifth leading cause of cancer death in men worldwide. If local PCa presents a favorable prognosis, available treatments for advanced PCa display limiting benefits due to therapeutic res
Externí odkaz:
https://doaj.org/article/da56329f987641acaf605adec640a2ba
Autor:
Jean Courcier, Alexandre de la Taille, Maya Nourieh, Ingrid Leguerney, Nathalie Lassau, Alexandre Ingels
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 19, p 7146 (2020)
Carbonic Anhydrase IX (CAIX) is a well-described enzyme in renal cell carcinoma, with its expression being regulated by the hypoxia-inducible factor 1 alpha, it is known for interfering with hypoxia processes. Renal carcinoma encompasses a broad spec
Externí odkaz:
https://doaj.org/article/5d88e787e4e54f34a137dae0f50ae29a
Publikováno v:
Histopathology. 82:162-169
The diagnosis, histomolecular classes of breast cancers (luminal A, luminal B, HER2-enriched, and basal-like), and accurate prediction of prognosis are commonly determined using morphological and phenotypical analyses in clinical practice worldwide.
Autor:
Yazid Belkacemi, Kamel Debbi, Gabriele Coraggio, Jérome Bendavid, Maya Nourieh, Nhu Hanh To, Mohamed Aziz Cherif, Carolina Saldana, Alexandre Ingels, Alexandre De La Taille, Gokoulakrichenane Loganadane
Publikováno v:
Cancers
Volume 15
Issue 3
Pages: 945
Volume 15
Issue 3
Pages: 945
Genomic classifiers such as the Genomic Prostate Score (GPS) could help to personalize treatment for men with intermediate-risk prostate cancer (I-PCa). In this study, we aimed to evaluate the ability of the GPS to change therapeutic decision making
Autor:
Maya Nourieh, Helene Boussion, Charlotte Joly, Gokoulakrichenane Loganadane, Christophe Tournigand, Yazid Belkacemi, Victoire de Salins, Emmanuelle Kempf, Mukedaisi Abulizi
Publikováno v:
World Journal of Clinical Oncology
BACKGROUND Oncocytic carcinoma of the thyroid is a rare disease, characterized by a poor prognosis and low response rate to radioiodine therapy. Crizotinib is a specific anaplastic lymphoma kinase (ALK) inhibitor, which was initially developed in non
Autor:
Gabriele, Coraggio, Shan, Husheng, Gokoulakrichenane, Loganadane, Sahar, Ghith, Noémie, Grellier, Marie Laure, Hervé, Nhu Hanh, To, Laurianne, Colson Durand, Annie, Jouhaud, Maryse, Fayolle Campana, Maya, Nourieh, Dimitri, Vordos, Yazid, Belkacemi
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 25(4)
The optimal schedule for palliative external beam radiotherapy (EBRT) in patients with bladder tumors with hematuria unfit for surgery remains undefined. This study aimed to assess the clinical hemostatic efficacy and safety of two EBRT hypofractiona
Autor:
L. Salomon, Y. Belkacemi, Gabriele Coraggio, A. Brunel, A. Hadhri, A. Jouhaud, Alexandre Ingels, W. Hassani, B. Vega Salazar, Maya Nourieh, A. de la Taille, Charlotte Joly
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 108:e864-e865
Autor:
Ingrid Leguerney, Alexandre Ingels, Alexandre de la Taille, Nathalie Lassau, Jean Courcier, Maya Nourieh
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 21, Iss 7146, p 7146 (2020)
International Journal of Molecular Sciences, Vol 21, Iss 7146, p 7146 (2020)
Carbonic Anhydrase IX (CAIX) is a well-described enzyme in renal cell carcinoma, with its expression being regulated by the hypoxia-inducible factor 1 alpha, it is known for interfering with hypoxia processes. Renal carcinoma encompasses a broad spec
Publikováno v:
Annales de Pathologie. 33:118-121